H5N1 News and Research

Latest H5N1 News and Research

New strain of avian flu kills two Chinese men, officials say

"Two people in China have died and another remains critical after falling ill with a strain of bird flu not detected before in humans, the official Chinese news agency Xinhua reported," CNN reports (Mullen, 4/1).

2 Apr 2013

New vaccine proves highly effective against H5N1 virus

Until now most experimental vaccines against the highly lethal H5N1 avian influenza virus have lacked effectiveness. But a new vaccine has proven highly effective against the virus when tested in both mice and ferrets. It is also effective against the H9 subtype of avian influenza.

26 Mar 2013

UCLA researchers predict hotspots for future outbreaks of influenza virus

This year's unusually long and rocky flu season would be nothing compared to the pandemic that could occur if bird flu became highly contagious among humans, which is why UCLA researchers and their colleagues are creating new ways to predict where an outbreak could emerge.

17 Mar 2013

NanoViricides retires Series C Convertible Preferred Stock previously purchased by Seaside

NanoViricides, Inc., announced today that it has retired the remainder of the Series C Convertible Preferred Stock previously purchased by Seaside 88, LP, with a cash payment.

27 Feb 2013

U.S. health officials outline new policies for funding research on H5N1 avian flu, other potentially dangerous agents

"U.S. health authorities on Thursday outlined the conditions for funding research on the H5N1 bird flu virus a month after scientists lifted a yearlong pause on the work that was imposed amid concerns it could be used by terrorists," Bloomberg reports.

23 Feb 2013

Cambodia, China report cases of avian influenza H5N1

"Cambodia reported on Wednesday that another four-year-old girl has contracted avian influenza H5N1, becoming the seventh person who infected the virus in 2013," Xinhua reports.

14 Feb 2013

Global response to possible H5N1 flu outbreak could affect epidemic's course

"It's been a rough flu season this winter in the United States and Europe, but it could be worse. A lot worse," science writer Carl Zimmer states in National Geographic's "Phenomena: The Loom" blog.

10 Feb 2013

CEL-SCI reports net loss of $2,310,246 for fiscal quarter ended December 31, 2012

CEL-SCI Corporation reports financial results for the fiscal quarter ended December 31, 2012.

10 Feb 2013

FluGen's REDEE FLU vaccine protects against both H5N1 and H3N2 strains

Deadly flu viruses, including the H5N1 bird flu and H3N2 swine flu, may have met their match in FluGen's universal vaccine, REDEE FLU.

6 Feb 2013

ASM to host 2013 Biodefense and Emerging Diseases Research Meeting from Feb. 25-27

The American Society for Microbiology (ASM) will host its 2013 Biodefense and Emerging Diseases Research Meeting February 25-27, 2013 at the Marriott Wardman Park Hotel in Washington, DC.

6 Feb 2013

Northeast Ohio Medical University, CEL-SCI produce new investigational breast cancer vaccine

CEL-SCI Corporation announced that its longstanding collaboration with Northeast Ohio Medical University has produced a new investigational breast cancer vaccine which prevents and treats a HER-2/neu expressing breast cancer tumor in a mouse model of the disease.

31 Jan 2013

Positive results from PaxVax's Ad4-H5-Vtn vector vaccine Phase 1 trial on avian flu

PaxVax, Inc., which develops and commercializes innovative vaccines against infectious diseases in a socially responsible manner, today announced positive results in a Phase 1 clinical trial for its oral, replicating adenovirus serotype 4 (Ad4) vector vaccine for H5N1 (avian flu).

31 Jan 2013

Cambodian health officials strengthen avian flu awareness campaigns after 2 more deaths

"Two more children have died in Cambodia of bird flu, bringing the number of fatal cases this year to four and the number of cases overall to five," the Associated Press/Wall Street Journal reports, noting only three cases were reported in all of 2012. "WHO says bird flu, also known as avian influenza, or H5N1, has killed 360 other people worldwide since surfacing in 2003," with most cases "linked to contact with infected poultry," the news agency writes.

30 Jan 2013

Have scientists thoroughly addressed avian flu research concerns?

Noting that a nearly yearlong moratorium on H5N1 avian influenza research, put in place "because of safety and terrorism concerns," was lifted recently, a New York Times editorial states, "We wish we could be as sanguine as they are that all the earlier concerns have been dealt with."

29 Jan 2013

New research sets out alternative approach to pandemic preparedness

'Evil' scientists, deadly viruses and terrorist plots are usually the preserve of Hollywood blockbusters. But when it comes to pandemic influenza, it is the stuff of real life. As controversy about research into the H5N1 bird flu virus continues, a new paper argues for a complete overhaul of current approaches to pandemic preparedness.

29 Jan 2013

Voluntary moratorium on H5N1 research ends; fate of U.S.-funded research unknown

"Almost a year after they announced it, leading influenza researchers are ending a voluntary moratorium on certain types of controversial experiments involving the H5N1 avian influenza virus."

25 Jan 2013

Yearlong moratorium on H5N1 research soon lifted, new rules implemented, Science reports

"U.S. government officials say they expect to put the finishing touches this month on new rules designed to help funding agencies identify and regulate especially problematic H5N1 studies before they begin," which would allow influenza researchers "to lift a year-old, self-imposed moratorium on certain kinds of potentially dangerous experiments," Science reports.

7 Jan 2013

NanoViricides to advance influenza drug candidate with completed $5M funding

NanoViricides, Inc., announced today that it has received the final tranche of $2.5M from Seaside 88, LP, thereby completing the total of a $5M financing. This raise, and the receipt of the initial $2.5M tranche, was previously announced on June 29, 2012.

25 Dec 2012

Voluntary moratorium on H5N1 avian flu research likely to end soon

Following the conclusion of a two-day meeting at the National Institutes of Health (NIH) this week -- meant "to gather feedback from flu researchers, others in the science community, and the public on its draft framework for funding H5N1 gain-of-function studies and to continue an international dialogue on issues related to benefits and risks of the research" -- "experts anticipated that a voluntary moratorium on work with lab-modified strains that have increased transmissibility might end soon," CIDRAP News reports.

21 Dec 2012

Researchers report seroprevalence of three avian flu virus strains in pigs in southern China

Researchers report for the first time the seroprevalence of three strains of avian influenza viruses in pigs in southern China, but not the H5N1 avian influenza virus. Their research, published online ahead of print in the Journal of Clinical Microbiology, has implications for efforts to protect the public health from pandemics.

20 Dec 2012

H5N1 News and Research

Latest H5N1 News and Research

New strain of avian flu kills two Chinese men, officials say

New vaccine proves highly effective against H5N1 virus

UCLA researchers predict hotspots for future outbreaks of influenza virus

NanoViricides retires Series C Convertible Preferred Stock previously purchased by Seaside

U.S. health officials outline new policies for funding research on H5N1 avian flu, other potentially dangerous agents

Cambodia, China report cases of avian influenza H5N1

Global response to possible H5N1 flu outbreak could affect epidemic's course

CEL-SCI reports net loss of $2,310,246 for fiscal quarter ended December 31, 2012

FluGen's REDEE FLU vaccine protects against both H5N1 and H3N2 strains

ASM to host 2013 Biodefense and Emerging Diseases Research Meeting from Feb. 25-27

Northeast Ohio Medical University, CEL-SCI produce new investigational breast cancer vaccine

Positive results from PaxVax's Ad4-H5-Vtn vector vaccine Phase 1 trial on avian flu

Cambodian health officials strengthen avian flu awareness campaigns after 2 more deaths

Have scientists thoroughly addressed avian flu research concerns?

New research sets out alternative approach to pandemic preparedness

Voluntary moratorium on H5N1 research ends; fate of U.S.-funded research unknown

Yearlong moratorium on H5N1 research soon lifted, new rules implemented, Science reports

NanoViricides to advance influenza drug candidate with completed $5M funding

Voluntary moratorium on H5N1 avian flu research likely to end soon

Researchers report seroprevalence of three avian flu virus strains in pigs in southern China

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

H5N1 News and Research

Latest H5N1 News and Research

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Newsletters you may be interested in